Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI).

No abstract is available for this paper.

• Publication year

  1986

• Venue

  The Lancet

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 2868337
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• A COMPARATIVE STUDY ON EFFICACY AND SAFETY OF STREPTOKINASE AND RETEPLASE IN PATIENTS WITH MYOCARDIAL INFARCTION IN A TERTIARY CARE TEACHING HOSPITAL

  2025cites this paper
• Use and misuse of composite endpoints in randomised clinical trials

  2025cites this paper
• 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2025cites this paper
• The History of Coronary Artery Disease

  2025cites this paper
• Benchmarking progress in non-communicable diseases: a global analysis of cause-specific mortality from 2001 to 2019

  2025cites this paper
• ANMCO position paper: functional reorganization of Intensive Cardiac Care Units (ICCUs) in Italy

  2025influential citation
• Thrombolysis in non-ST-elevation myocardial infarction: systematic review and meta-analysis of randomised controlled trials

  2025cites this paper
• Impact of telemedicine in STEMI care system: A five-year experience from Tamil Nadu, India

  2025cites this paper
• Beyond Direct Fibrinolysis: Novel Approaches to Thrombolysis

  2025cites this paper
• Heart Disease Mortality in the United States, 1970 to 2022

  2025cites this paper
• Mobile cardiac catheterization for critical cardiovascular disease: a feasibility and applicability study.

  2025cites this paper
• 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2025cites this paper
• Fibrinolytic Therapy for Thromboembolic Diseases: Approved Indications and Future Directions.

  2025cites this paper
• Brazilian Guideline for the Evaluation and Diagnosis of Chest Pain in the Emergency Department - 2025.

  2025cites this paper
• State of the Art of Primary PCI: Present and Future

  2025cites this paper
• Interpretando o Infarto Agudo do Miocárdio 40 Anos Depois. Evolução do Conhecimento: Qual a Melhor Explicação?

  2024cites this paper
• Evaluación de la función sistólica del ventrículo derecho en pacientes con infarto agudo de miocardio con elevación del segmento ST sometidos a estrategia farmacoinvasiva o angioplastia primaria

  2024cites this paper
• Aspirin is a life-saving drug for patients with acute myocardial infarction

  2024cites this paper
• Fibrinolytic uses in the emergency department: a narrative review.

  2024cites this paper
• Composite end points and competing risks analysis

  2024cites this paper
• Clinical, electrocardiographic, echocardiographic, and angiographic predictors for the final infarct size assessed by cardiac magnetic resonance in acute STEMI patients after primary percutaneous coronary intervention

  2024cites this paper
• The American Heart Association at 100: A Century of Scientific Progress and the Future of Cardiovascular Science: A Presidential Advisory From the American Heart Association.

  2024cites this paper
• Acute myocardial infarction and ischaemic stroke: differences and similarities in reperfusion therapies-a review.

  2024cites this paper
• Beyond the classic major cardiovascular event outcome for cardiovascular trials.

  2024cites this paper
• Pre-Hospital Delay and Outcomes in Myocardial Infarction With Nonobstructive Coronary Arteries

  2024cites this paper
• Defining the exit meta-analysis

  2024cites this paper
• The Safety and Efficacy of the Early Use of Sacubitril/Valsartan After Acute Myocardial Infarction: A Meta-Analysis of Randomized Controlled Trials

  2024cites this paper
• Cardiogenic shock in the context of acute coronary syndromes in Latin America ("LATIN Shock").

  2024cites this paper
• The Revolution of STEMI Care: A Story of Resilience, Persistence, and Success

  2024cites this paper
• KATP channels and cardioprotection.

  2024cites this paper
• Bleeding characteristics and mortality outcomes following ST-elevation myocardial infarction thrombolysis: a 5-year analysis in an Asian population.

  2024cites this paper
• From symptom onset to ED departure: understanding the acute care chain for patients with undifferentiated complaints: a prospective observational study

  2024cites this paper
• Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved Indications

  2024cites this paper
• Intravenous Thrombolysis in an Endovascular Treatment–Dominant Era: What Does the Future Hold?

  2023cites this paper
• Ischemia Reperfusion Injury

  2023cites this paper
• Milestones in the history of neurocritical care

  2023cites this paper
• Italian contributions to the history of acute myocardial infarction treatment.

  2023cites this paper
• STEMI-Related Mortality: Don't Stop Believin'.

  2023cites this paper
• Critical Appraisal of the Current Role of Myocardial Perfusion Imaging in the Management of Acute Chest Pain.

  2023cites this paper
• Clinical and Basic Cardiology

  2023cites this paper
• Don’t go breakin’ my heart: cardioprotective alterations to the mechanical and structural properties of reperfused myocardium during post-infarction inflammation

  2023cites this paper
• The outcomes of reperfusion therapy with streptokinase versus tenecteplase in ST-elevation myocardial infarction (STEMI): a propensity-matched retrospective analysis in an Asian population

  2022cites this paper
• Comparison of Prognosis According to the Use of Emergency Medical Services in Patients with ST-Segment Elevation Myocardial Infarction

  2022cites this paper
• Randomized trials fit for the 21st century. A joint opinion from the European Society of Cardiology, American Heart Association, American College of Cardiology, and the World Heart Federation

  2022cites this paper
• From Q/Non-Q Myocardial Infarction to STEMI/NSTEMI: Why It’s Time to Consider Another Simplified Dichotomy; a Narrative Literature Review

  2022cites this paper
• Closing gaps in medication taking for secondary prevention of coronary heart disease patients among US adults

  2022cites this paper
• Late Presenters with ST-Elevation Myocardial Infarction: A Call to Action

  2022cites this paper
• Early Clinical Management of Sepsis: Past, Present, and Future

  2022cites this paper
• A training project to promote clinical research among young cardiologists.

  2022cites this paper
• Type 2 MI and Myocardial Injury in the Era of High-sensitivity Troponin

  2022cites this paper
• The Reduction of Mortality in Acute Myocardial Infarction: From Bed Rest to Future Directions

  2022cites this paper
• Randomized Trials Fit for the 21st Century: A Joint Opinion From the European Society of Cardiology, American Heart Association, American College of Cardiology, and the World Heart Federation.

  2022cites this paper
• Randomized Trials Fit for the 21st Century. A Joint Opinion from the European Society of Cardiology, American Heart Association, American College of Cardiology, and the World Heart Federation

  2022cites this paper
• Percutaneous Myocardial Revascularization in Late-Presenting Patients With STEMI.

  2021cites this paper
• Comparative Study of Outcome of Patients with ST-Segment Elevation Myocardial Infarction in Diabetics and Non-Diabetics

  2021cites this paper
• Thrombolytic Enzymes of Microbial Origin: A Review

  2021cites this paper
• Thrombolysis In Myocardial Infarction (TIMI) Study Group: JACC Focus Seminar 2/8.

  2021cites this paper
• Overview of Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) Support for the Management of Cardiogenic Shock

  2021cites this paper
• Reperfusão Coronariana no Infarto Agudo do Miocárdio: Tentar o Ótimo. Executar o Possível

  2021cites this paper
• The RECOVERY trial platform: a milestone in the development and execution of treatment evaluation during an epidemic

  2021cites this paper
• Time for a new paradigm shift in myocardial infarction.

  2021cites this paper
• Thrombolytic Therapy for ST-Elevation Myocardial Infarction Presenting to non-Percutaneous Coronary Intervention Centers During the COVID-19 Crisis

  2021cites this paper
• Diagnosis and Management of Late-presentation ST-elevation Myocardial Infarction and Complications.

  2021cites this paper
• Cardiac Regeneration: New Insights Into the Frontier of Ischemic Heart Failure Therapy

  2021cites this paper
• Temporal association of contamination obsession on the prehospital delay of STEMI during COVID-19 pandemic

  2021cites this paper
• Fibrinolytic Therapy in Patients with Acute ST-elevation Myocardial Infarction.

  2021cites this paper
• Chemokines in Myocardial Infarction

  2020cites this paper
• Inferior ST-Elevation Myocardial Infarction Presenting When Urgent Primary Percutaneous Coronary Intervention Is Unavailable: Should We Adhere to Current Guidelines?

  2020cites this paper
• The Impact of Advanced Age on Major Cardiovascular Events and Mortality in Patients with ST-Elevation Myocardial Infarction Undergoing a Pharmaco-Invasive Strategy

  2020cites this paper
• Transitioning from a coronary to a critical cardiovascular care unit: trends over the past three decades.

  2020cites this paper
• Geriatric Nutritional Risk Index Score Predicts Clinical Outcome in Patients With Acute ST-Segment Elevation Myocardial Infarction.

  2020cites this paper
• Methodological education in response to the quality of COVID-19 publications

  2020cites this paper
• Inferior Wall Myocardial Infarction, Acute Coronary Syndrome, Double-vessel Diseases, Chronic Venous Thrombosis, and Type II Diabetes Mellitus

  2020cites this paper
• Angiographic outcomes in STEMI patients receiving fibrinolysis with guideline directed optimal antithrombotic therapy

  2020cites this paper
• Comparison of Real-Life Systems of Care for ST-Segment Elevation Myocardial Infarction

  2020cites this paper
• The median and the mode as robust meta‐analysis estimators in the presence of small‐study effects and outliers

  2020cites this paper
• And fibrinolysis became pharmacoinvasive.

  2020cites this paper
• Fibrinolytiques

  2020cites this paper
• [The Bleeding Safety of Ticagrelor in Patients With ST-Elevation Acute Coronary Syndrome Treated With Fibrinolytic Therapy].

  2020cites this paper
• No-reflow phenomenon and comparison to the normal-flow population postprimary percutaneous coronary intervention for ST elevation myocardial infarction: case–control study (NORM PPCI)

  2020cites this paper
• Coronary flow reserve is related to the extension and transmurality of myocardial necrosis and predicts functional recovery after acute myocardial infarction

  2019cites this paper
• JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome.

  2019cites this paper
• COMPLICATIONS OF STREPTOKINASE IN PATIENTS WITH ACUTE ST SEGMENT ELEVATION MYOCARDIAL INFARCTION: NO REASON TO WITHHOLD THIS EFFECTIVE THERAPY

  2019cites this paper
• Antiplatelet Therapy

  2019cites this paper
• Optimal measuring point for ST deviation in chest pain patients with possible acute coronary syndrome.

  2019cites this paper
• In-hospital management and intermediate term outcomes in stable patients with ST segment elevation myocardial infarction presenting between 12-48 hours of symptom onset versus 2-7 days after the onset of chest pain; a single center study.

  2019cites this paper
• 2019 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Guidelines on the Acute Management of ST-Elevation Myocardial Infarction: Focused Update on Regionalization and Reperfusion.

  2019cites this paper
• Reflections on the design and analysis of clinical trials and meta-analyses in the 1970s and 1980s

  2019cites this paper
• [Antithrombotic therapy of coronary heart disease: time - tested essential principles].

  2019cites this paper
• Fibrinolytic Enzymes for Thrombolytic Therapy.

  2019cites this paper
• Perioperative ST-elevation myocardial infarction: with time of the essence, is there a case for guidelines?

  2019cites this paper
• Short-term triggers, treatment optimisation and risk stratification

  2019cites this paper
• Diagnosis, Management, and Prognosis of Myocardial Infarction (MI)

  2019cites this paper
• Embedding patient- and public health-oriented research in a national health service: the GISSI experience

  2019cites this paper
• Evolving management and improving outcomes of pregnancy-associated spontaneous coronary artery dissection (P-SCAD): a systematic review

  2018cites this paper
• Markers of Reperfusion and Long-Term (8-Year) Prognosis after Primary Percutaneous Coronary Intervention.

  2018cites this paper
• Heart failure complicating myocardial infarction. A report of the Peruvian Registry of ST-elevation myocardial infarction (PERSTEMI).

  2018cites this paper
• Acute Myocardial Infarction and Primary Percutaneous Coronary Intervention at Night Time

  2018cites this paper
• Drug-Coated Balloons in STEMI

  2018cites this paper
• The Streptokinase Therapy Complications and its Associated Risk Factors in Patients with Acute ST Elevation Myocardial Infarction

  2018cites this paper